8-K Announcements
6Material company update
May 4, 2026·SEC
Material company update
Apr 23, 2026·SEC
Material company update
Feb 17, 2026·SEC
Masimo Corporation(MASI)Earnings, Financials & Key Ratios
MASI•NASDAQ
Price updated Jun 19, 2026
AboutMasimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.Show more
- Revenue$1.53B-27.1%
- EBITDA$352M+314.8%
- Net Income-$152M+50.3%
- EPS (Diluted)-2.80+51.0%
- Gross Margin61.9%+29.1%
- EBITDA Margin23.03%+394.6%
- Operating Margin20.49%+260.9%
- Net Margin-9.92%+31.8%
- ROE-17.09%+32.3%
MASI Key Insights
Masimo Corporation (MASI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading near 52-week high
✗Weaknesses
- ✗Thin 5Y average net margin of 1.0%
- ✗Expensive at 13.5x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when MASI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MASI Price & Volume
Masimo Corporation (MASI) stock price & volume — 10-year historical chart
Loading chart...
MASI Growth Metrics
Masimo Corporation (MASI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years9.25%
5 Years5.95%
3 Years-9.14%
TTM-14.42%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM115.43%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM115.84%
Return on Capital
10 Years21.11%
5 Years8.01%
3 Years4.09%
Last Year18.76%
MASI Recent Earnings
Masimo Corporation (MASI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$1.43+1.4%
$1.41
Rev
$400M+0.2%
$399M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.18-87.8%
$1.48
Rev
$413M+1.1%
$408M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$1.32+10.9%
$1.19
Rev
$372M-8.9%
$408M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$1.33+8.1%
$1.23
Rev
$371M+0.5%
$369M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $1.43vs $1.41+1.4% | $400Mvs $399M+0.2% |
| Q1 2026 | Feb 26, 2026 | $0.18vs $1.48-87.8% | $413Mvs $408M+1.1% |
| Q4 2025 | Nov 4, 2025 | $1.32vs $1.19+10.9% | $372Mvs $408M-8.9% |
| Q3 2025 | Aug 5, 2025 | $1.33vs $1.23+8.1% | $371Mvs $369M+0.5% |
Based on last 12 quarters of dataView full earnings history →
MASI Peer Comparison
Masimo Corporation (MASI) competitors in Patient monitoring and respiratory care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PODD | 10.23B | 145.76 | 41.89 | 30.73% | 10.44% | 21.38% | 0.69 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ITGR | 3.13B | 90.96 | 31.47 | 7.57% | 7.67% | 8.23% | 0.80 | |
 ICUI | 3.51B | 140.37 | 4774.49 | -6.38% | 2.15% | 2.19% | 0.66 | |
 NTRA | 33.14B | 231.41 | -152.24 | 35.9% | -9.05% | -15.13% | 0.13 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 NOVT | 5.53B | 155.30 | 105.65 | 3.3% | 5.35% | 5.08% | 0.26 |
Compare MASI vs Peers
Masimo Corporation (MASI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MASI Income Statement
Masimo Corporation (MASI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 790.25M | 858.29M | 937.84M | 1.14B | 1.24B | 2.04B | 2.05B | 2.09B | 1.53B | 1.56B |
Revenue Growth % | 10.85% | 8.61% | 9.27% | 21.95% | 8.35% | 64.28% | 0.6% | 2.26% | -27.1% | -14.42% |
Cost of Goods Sold | 268.22M | 283.4M | 308.67M | 400.7M | 430.8M | 977M | 1.04B | 1.09B | 581.7M | 596.5M |
COGS % of Revenue | 33.94% | 33.02% | 32.91% | 35.04% | 34.76% | 47.99% | 51% | 52.04% | 38.1% | - |
Gross Profit | 522.03M▲ 0% | 574.89M▲ 10.1% | 629.17M▲ 9.4% | 743M▲ 18.1% | 808.4M▲ 8.8% | 1.06B▲ 31.0% | 1B▼ 5.2% | 1B▲ 0.1% | 945.2M▼ 5.9% | 962M▲ 0% |
Gross Margin % | 66.06% | 66.98% | 67.09% | 64.96% | 65.24% | 52.01% | 49% | 47.96% | 61.9% | 61.73% |
Gross Profit Growth % | 9.13% | 10.13% | 9.44% | 18.09% | 8.8% | 30.97% | -5.22% | 0.09% | -5.89% | - |
Operating Expenses | 338.25M | 366.85M | 407.96M | 487.2M | 532.6M | 848.8M | 867M | 1.27B | 632.4M | 652.6M |
OpEx % of Revenue | 42.8% | 42.74% | 43.5% | 42.6% | 42.98% | 41.69% | 42.33% | 60.69% | 41.42% | - |
Selling, General & Admin | 273.01M | 285.42M | 314.66M | 369M | 395.4M | 657.4M | 664M | 743.8M | 506M | 530M |
SG&A % of Revenue | 34.55% | 33.25% | 33.55% | 32.26% | 31.91% | 32.29% | 32.42% | 35.51% | 33.14% | - |
Research & Development | 65.23M | 81.01M | 93.3M | 118.7M | 137.2M | 191.4M | 175.2M | 222.8M | 126.4M | 122.5M |
R&D % of Revenue | 8.25% | 9.44% | 9.95% | 10.38% | 11.07% | 9.4% | 8.55% | 10.64% | 8.28% | - |
Other Operating Expenses | 0 | 425K | 0 | -500K | 0 | 0 | 27.8M | 304.5M | 0 | 100K |
Operating Income | 183.79M▲ 0% | 208.04M▲ 13.2% | 221.22M▲ 6.3% | 255.8M▲ 15.6% | 275.8M▲ 7.8% | 210M▼ 23.9% | 136.5M▼ 35.0% | -266.7M▼ 295.4% | 312.8M▲ 217.3% | 309.4M▲ 0% |
Operating Margin % | 23.26% | 24.24% | 23.59% | 22.37% | 22.26% | 10.32% | 6.66% | -12.73% | 20.49% | 19.85% |
Operating Income Growth % | -57.84% | 13.2% | 6.33% | 15.63% | 7.82% | -23.86% | -35% | -295.38% | 217.29% | - |
EBITDA | 203.85M | 229.17M | 244.7M | 285.1M | 311.4M | 346.1M | 234.8M | -163.7M | 351.6M | 339.6M |
EBITDA Margin % | 25.8% | 26.7% | 26.09% | 24.93% | 25.13% | 17% | 11.46% | -7.82% | 23.03% | 21.79% |
EBITDA Growth % | -54.98% | 12.42% | 6.78% | 16.51% | 9.22% | 11.14% | -32.16% | -169.72% | 314.78% | 415.91% |
D&A (Non-Cash Add-back) | 20.06M | 21.13M | 23.49M | 29.3M | 35.6M | 136.1M | 98.3M | 103M | 38.8M | 30.2M |
EBIT | 186.48M | 214.48M | 234.49M | 264M | 274.7M | 219.1M | 138.4M | -261.7M | 305.8M | 306.2M |
Net Interest Income | 2.3M | 7.47M | 13.59M | 5.2M | 600K | -23.9M | -47.3M | -38.8M | -29.8M | -22.4M |
Interest Income | 2.97M | 8.18M | 13.92M | 5.53M | 900K | 1.8M | 3M | 4.8M | 3.4M | 2.1M |
Interest Expense | 678K | 706K | 328K | 338K | 300K | 25.7M | 50.3M | 43.6M | 33.2M | 24.5M |
Other Income/Expense | 2.01M | 5.73M | 12.95M | 7.9M | -1.4M | -16.6M | -48.4M | -38.6M | -40.2M | -33.8M |
Pretax Income | 185.8M▲ 0% | 213.78M▲ 15.1% | 234.17M▲ 9.5% | 263.7M▲ 12.6% | 274.4M▲ 4.1% | 193.4M▼ 29.5% | 88.1M▼ 54.4% | -305.3M▼ 446.5% | 272.6M▲ 189.3% | 275.6M▲ 0% |
Pretax Margin % | 23.51% | 24.91% | 24.97% | 23.06% | 22.14% | 9.5% | 4.3% | -14.58% | 17.85% | 17.68% |
Income Tax | 61.01M | 20.23M | 37.95M | 23.4M | 44.8M | 49.9M | 6.6M | -400K | 64.9M | 58.8M |
Effective Tax Rate % | 32.84% | 9.46% | 16.21% | 8.87% | 16.33% | 25.8% | 7.49% | 0.13% | 23.81% | 21.34% |
Net Income | 131.62M▲ 0% | 193.54M▲ 47.1% | 196.22M▲ 1.4% | 240.3M▲ 22.5% | 229.6M▼ 4.5% | 143.5M▼ 37.5% | 81.5M▼ 43.2% | -304.9M▼ 474.1% | -151.5M▲ 50.3% | 76.3M▲ 0% |
Net Margin % | 16.66% | 22.55% | 20.92% | 21.01% | 18.53% | 7.05% | 3.98% | -14.56% | -9.92% | 4.9% |
Net Income Growth % | -56.23% | 47.05% | 1.38% | 22.47% | -4.45% | -37.5% | -43.21% | -474.11% | 50.31% | 115.43% |
Net Income (Continuing) | 124.79M | 193.54M | 196.22M | 240.3M | 229.6M | 143.5M | 81.5M | -304.9M | 207.7M | 217.6M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -359.2M | 1000K |
Minority Interest | 0 | 0 | 0 | -20K | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 2.23▲ 0% | 3.45▲ 54.7% | 3.44▼ 0.3% | 4.14▲ 20.3% | 3.98▼ 3.9% | 2.60▼ 34.7% | 1.51▼ 41.9% | -5.72▼ 478.8% | -2.80▲ 51.0% | 1.45▲ 0% |
EPS Growth % | -61.88% | 54.71% | -0.29% | 20.35% | -3.86% | -34.67% | -41.92% | -478.81% | 51.05% | 115.84% |
EPS (Basic) | 2.42 | 3.45 | 3.67 | 4.39 | 4.16 | 2.68 | 1.54 | -5.72 | -2.83 | - |
Diluted Shares Outstanding | 55.87M | 56.04M | 57.1M | 58.04M | 57.68M | 55.2M | 54.1M | 53.3M | 54.2M | 52.6M |
Basic Shares Outstanding | 51.52M | 56.04M | 53.43M | 54.7M | 55.17M | 53.6M | 52.8M | 53.3M | 53.6M | 52.2M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
MASI Balance Sheet
Masimo Corporation (MASI) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 559.7M | 789.28M | 996.06M | 1.1B | 1.24B | 1.31B | 1.23B | 1.23B | 926M | 870.5M |
Cash & Short-Term Investments | 315.3M | 552.49M | 687.69M | 641.45M | 745.3M | 202.9M | 163M | 177.6M | 152.3M | 124.6M |
Cash Only | 315.3M | 552.49M | 567.69M | 641.45M | 745.3M | 202.9M | 163M | 177.6M | 152.3M | 124.6M |
Short-Term Investments | 0 | 0 | 120M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 135.26M | 120.42M | 166.84M | 181.38M | 244.69M | 505.1M | 421M | 489.3M | 366.6M | 288.9M |
Days Sales Outstanding | 62.48 | 51.21 | 64.93 | 57.89 | 72.07 | 90.56 | 75.03 | 85.27 | 87.63 | 79.86 |
Inventory | 92.26M | 94.73M | 115.87M | 215.95M | 201.4M | 501M | 545M | 459.2M | 380.3M | 400M |
Days Inventory Outstanding | 125.55 | 122.01 | 137.02 | 196.71 | 170.64 | 187.17 | 190.43 | 153.77 | 238.63 | 219.89 |
Other Current Assets | 2.86M | 8.48M | 4.79M | 10.91M | 6.7M | 6M | 10.5M | 24.4M | 26.8M | 3.7M |
Total Non-Current Assets | 345.74M | 365.54M | 400.07M | 611.39M | 648.1M | 1.9B | 1.81B | 1.4B | 772.9M | 772.2M |
Property, Plant & Equipment | 164.1M | 165.97M | 239.06M | 306.17M | 303.3M | 472.1M | 483.5M | 456M | 355.1M | 388M |
Fixed Asset Turnover | 4.82x | 5.17x | 3.92x | 3.74x | 4.09x | 4.31x | 4.24x | 4.59x | 4.30x | 4.29x |
Goodwill | 20.62M | 23.3M | 22.35M | 103.21M | 100.3M | 445.4M | 407.7M | 96.7M | 101M | 100.9M |
Intangible Assets | 27.12M | 27.92M | 27.25M | 73.92M | 72.5M | 722.6M | 652.3M | 558.2M | 52.1M | 51M |
Long-Term Investments | 1.23M | 1.2M | 6.47M | 8M | 13.8M | 13.8M | 9.9M | 8.6M | 71.3M | 200.7M |
Other Non-Current Assets | 112.69M | 125.94M | 68.95M | 80.72M | 105.6M | 145.6M | 149M | 136.8M | 79.2M | 45.3M |
Total Assets | 905.44M▲ 0% | 1.15B▲ 27.5% | 1.4B▲ 20.9% | 1.71B▲ 22.7% | 1.89B▲ 10.2% | 3.21B▲ 70.1% | 3.04B▼ 5.3% | 2.63B▼ 13.7% | 1.7B▼ 35.3% | 1.64B▲ 0% |
Asset Turnover | 0.87x | 0.74x | 0.67x | 0.67x | 0.66x | 0.63x | 0.67x | 0.80x | 0.90x | 0.82x |
Asset Growth % | 10.35% | 27.54% | 20.9% | 22.66% | 10.19% | 70.14% | -5.27% | -13.67% | -35.3% | -121.78% |
Total Current Liabilities | 151.57M | 147.61M | 172.22M | 233.84M | 267.7M | 630M | 563.8M | 617.7M | 371.6M | 325.4M |
Accounts Payable | 33.78M | 40.39M | 54.55M | 64.06M | 75.6M | 276.8M | 251.5M | 252.8M | 103M | 89M |
Days Payables Outstanding | 45.97 | 52.02 | 64.5 | 58.35 | 64.05 | 103.41 | 87.88 | 84.65 | 64.63 | 68.17 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 15.1M | 34.3M | 37.3M | 14.4M | 14.5M |
Deferred Revenue (Current) | 32.1M | 32.05M | 11.76M | 28.98M | 29.9M | 36M | 37.4M | 46.8M | 73.2M | 191.9M |
Other Current Liabilities | 41.85M | 51.36M | 56.39M | 75.7M | 75.5M | 95.4M | 69.3M | 93.2M | 181M | 106.5M |
Current Ratio | 3.69x | 5.35x | 5.78x | 4.71x | 4.63x | 2.08x | 2.18x | 1.98x | 2.49x | 2.68x |
Quick Ratio | 3.08x | 4.71x | 5.11x | 3.79x | 3.87x | 1.28x | 1.22x | 1.24x | 1.47x | 1.45x |
Cash Conversion Cycle | 142.06 | 121.2 | 137.45 | 196.25 | 178.66 | 174.32 | 177.58 | 154.39 | 261.63 | 231.58 |
Total Non-Current Liabilities | 51.76M | 39.2M | 56.03M | 71.08M | 69.1M | 1.24B | 1.11B | 956.1M | 606.1M | 528.4M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 941.6M | 871.7M | 727.9M | 518M | 445.7M |
Capital Lease Obligations | 0 | 0 | 15.83M | 28.37M | 26.3M | 53.4M | 45.8M | 59.5M | 26.9M | 92.6M |
Deferred Tax Liabilities | 9.88M | 2.96M | 3.05M | 6.25M | 5.1M | 163.6M | 111.7M | 100.1M | 26.4M | 84.8M |
Other Non-Current Liabilities | 41.64M | 35.56M | 37.15M | 36.46M | 32.5M | 58.1M | 57.3M | 41.2M | 11.8M | 5.9M |
Total Liabilities | 181.41M | 185.75M | 228.25M | 304.91M | 336.8M | 1.87B | 1.68B | 1.57B | 977.7M | 853.8M |
Total Debt | 0 | 0 | 20.49M | 34.35M | 32.7M | 1.03B | 970M | 846.1M | 559.3M | 485.9M |
Net Debt | -315.3M | -552.49M | -547.2M | -607.1M | -712.6M | 825.9M | 807M | 668.5M | 407M | 361.3M |
Debt / Equity | - | - | 0.02x | 0.02x | 0.02x | 0.77x | 0.71x | 0.80x | 0.78x | 0.62x |
Debt / EBITDA | - | - | 0.08x | 0.12x | 0.11x | 2.97x | 4.13x | - | 1.59x | 1.43x |
Net Debt / EBITDA | -1.55x | -2.41x | -2.24x | -2.13x | -2.29x | 2.39x | 3.44x | - | 1.16x | 1.06x |
Interest Coverage | 275.04x | 303.80x | 714.92x | 781.07x | 915.67x | 8.53x | 2.75x | -6.00x | 9.21x | 12.50x |
Total Equity | 724.02M▲ 0% | 969.07M▲ 33.8% | 1.17B▲ 20.5% | 1.41B▲ 20.5% | 1.55B▲ 10.1% | 1.34B▼ 13.6% | 1.36B▲ 1.9% | 1.05B▼ 22.9% | 721.2M▼ 31.4% | 788.9M▲ 0% |
Equity Growth % | 29.24% | 33.84% | 20.52% | 20.53% | 10.13% | -13.63% | 1.93% | -22.93% | -31.44% | -116.54% |
Book Value per Share | 12.96 | 17.29 | 20.45 | 24.25 | 26.87 | 24.26 | 25.23 | 19.74 | 13.31 | 15.00 |
Total Shareholders' Equity | 724.02M | 969.07M | 1.17B | 1.41B | 1.55B | 1.34B | 1.36B | 1.05B | 721.2M | 788.9M |
Common Stock | 52K | 53K | 54K | 55K | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 737.96M | 931.07M | 1.1B | 1.34B | 1.57B | 1.71B | 1.8B | 1.49B | 1.34B | 1.4B |
Treasury Stock | -472.54M | -489.03M | -526.58M | -638.74M | -767.7M | -1.17B | -1.17B | -1.17B | -1.53B | -1.53B |
Accumulated OCI | -2.94M | -6.2M | -6.72M | 1.41M | -5.5M | 11.5M | -45.3M | -108.2M | -12.5M | -13.2M |
Minority Interest | 0 | 0 | 0 | -20K | 0 | 0 | 0 | 0 | 0 | 0 |
MASI Cash Flow Statement
Masimo Corporation (MASI) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 58.11M | 239.53M | 221.64M | 211.1M | 264.6M | 29.4M | 94.1M | 196.4M | 217.8M | 233.5M |
Operating CF Margin % | 7.35% | 27.91% | 23.63% | 18.46% | 21.35% | 1.44% | 4.59% | 9.38% | 14.26% | - |
Operating CF Growth % | -86.06% | 312.21% | -7.47% | -4.76% | 25.34% | -88.89% | 220.07% | 108.71% | 10.9% | 185.31% |
Net Income | 131.62M | 193.54M | 196.22M | 240.3M | 229.6M | 143.5M | 81.5M | -304.9M | -151.5M | 76.3M |
Depreciation & Amortization | 20.06M | 21.13M | 23.49M | 29.3M | 35.6M | 136.1M | 98.3M | 103M | 38.8M | 38.2M |
Stock-Based Compensation | 17.19M | 27.42M | 39.23M | 42.2M | 44.7M | 47.7M | 7M | 41.5M | 35.8M | 26.3M |
Deferred Taxes | 24.02M | -8.27M | -5.96M | -5M | -15.1M | -39.3M | -35.6M | -38.2M | 11.8M | 5.9M |
Other Non-Cash Items | 11.25M | -1.51M | 1.04M | 700K | 1.3M | 3.2M | 13.8M | 405.7M | 372.2M | -434M |
Working Capital Changes | -146.03M | 7.22M | -32.38M | -96.4M | -31.5M | -261.8M | -70.9M | -10.7M | -89.9M | -56.3M |
Change in Receivables | -19.77M | 10.83M | -35.54M | -9.9M | -76.9M | -151.3M | 91.9M | -60.2M | 17.2M | 53.6M |
Change in Inventory | -22.92M | -1.89M | -21.26M | -94.4M | 13.5M | -155.9M | -69.2M | -7.5M | -112.1M | -127.9M |
Change in Payables | -4.06M | 5.21M | 9.93M | 7.6M | 11M | 60.5M | -19.6M | 14.8M | -27.1M | -52.7M |
Cash from Investing | -47.91M | -26.15M | -197.68M | -82.8M | -37.5M | -1.06B | -81.2M | -51.2M | 275.1M | 260.2M |
Capital Expenditures | -46.76M | -22.68M | -68.38M | -72.5M | -25.5M | -52.8M | -44M | -20M | -19.4M | -22.3M |
CapEx % of Revenue | 5.92% | 2.64% | 7.29% | 6.34% | 2.06% | 2.59% | 2.15% | 0.95% | 1.27% | 1.43% |
Acquisitions | 0 | -3.92M | 0 | -116.1M | 0 | -999.7M | 7.5M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -4.22M | 453K | -9.31M | -14.2M | -12M | -5.2M | -44.7M | -31.2M | 294.5M | 282.5M |
Cash from Financing | -4.14M | 25.78M | -9.34M | -54.3M | -122.4M | 520.4M | -57.1M | -125.6M | -520.7M | -472.9M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 948.5M | -51.2M | -139M | -207.8M | -129M |
Equity Issued (Net) | -4.07M | 26.27M | -9.22M | -52.1M | -105.7M | -393.4M | 7M | 25.2M | -292.3M | -335.4M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -66.27M | -18.48M | -37.55M | -110.5M | -128.9M | -401.5M | 0 | 0 | -363.7M | -363.7M |
Other Financing | -71K | -490K | -123K | -2.2M | -16.7M | -34.7M | -12.9M | -11.8M | -20.6M | -8.5M |
Net Change in Cash | 7.29M▲ 0% | 237.16M▲ 3155.4% | 15.43M▼ 93.5% | 76.9M▲ 398.3% | 103.4M▲ 34.5% | -538.8M▼ 621.1% | -41.4M▲ 92.3% | 13.2M▲ 131.9% | 26M▲ 97.0% | 20.6M▲ 0% |
Free Cash Flow | 11.35M▲ 0% | 216.84M▲ 1811.4% | 149.15M▼ 31.2% | 131.2M▼ 12.0% | 229.7M▲ 75.1% | -26.9M▼ 111.7% | 6.4M▲ 123.8% | 145.3M▲ 2170.3% | 197.8M▲ 36.1% | 211.3M▲ 0% |
FCF Margin % | 1.44% | 25.26% | 15.9% | 11.47% | 18.54% | -1.32% | 0.31% | 6.94% | 12.95% | 13.56% |
FCF Growth % | -97.11% | 1811.36% | -31.22% | -12.03% | 75.08% | -111.71% | 123.79% | 2170.31% | 36.13% | 54.01% |
FCF per Share | 0.20 | 3.87 | 2.61 | 2.26 | 3.98 | -0.49 | 0.12 | 2.73 | 3.65 | 4.02 |
FCF Conversion (FCF/Net Income) | 0.44x | 1.24x | 1.13x | 0.88x | 1.15x | 0.20x | 1.15x | -0.64x | -1.44x | 2.77x |
Interest Paid | 551K | 193K | 211K | 300K | 300K | 23M | 51M | 39.1M | 0 | 4.7M |
Taxes Paid | 91.06M | 36.59M | 42.27M | 39.5M | 43.9M | 87.3M | 54.4M | 41.9M | 0 | 22.3M |
MASI Key Ratios
Masimo Corporation (MASI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 20.5% | 22.86% | 18.36% | 18.66% | 15.52% | 9.93% | 6.03% | -25.23% | -17.09% | 9.08% |
Return on Invested Capital (ROIC) | 41.58% | 37.81% | 31.99% | 27% | 25.25% | 10.49% | 4.72% | -10.28% | 16.47% | 18.96% |
Gross Margin | 66.06% | 66.98% | 67.09% | 64.96% | 65.24% | 52.01% | 49% | 47.96% | 61.9% | 61.73% |
Net Margin | 16.66% | 22.55% | 20.92% | 21.01% | 18.53% | 7.05% | 3.98% | -14.56% | -9.92% | 4.9% |
Debt / Equity | - | - | 0.02x | 0.02x | 0.02x | 0.77x | 0.71x | 0.80x | 0.78x | 0.62x |
Interest Coverage | 275.04x | 303.80x | 714.92x | 781.07x | 915.67x | 8.53x | 2.75x | -6.00x | 9.21x | 12.50x |
FCF Conversion | 0.44x | 1.24x | 1.13x | 0.88x | 1.15x | 0.20x | 1.15x | -0.64x | -1.44x | 2.77x |
Revenue Growth | 10.85% | 8.61% | 9.27% | 21.95% | 8.35% | 64.28% | 0.6% | 2.26% | -27.1% | -14.42% |
Related:MASI Dividend History·MASI Revenue History·MASI Price History·MASI P/E History·MASI Financial Ratios·MASI Institutional Holders
MASI SEC Filings & Documents
Masimo Corporation (MASI) SEC filings — annual & quarterly reports (10-K, 10-Q)
MASI Frequently Asked Questions
Masimo Corporation (MASI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Masimo Corporation (MASI) reported $1.56B in revenue for fiscal year 2025. This represents a 91576% increase from $1.7M in 1998.
Masimo Corporation (MASI) saw revenue decline by 27.1% over the past year.
Yes, Masimo Corporation (MASI) is profitable, generating $76.3M in net income for fiscal year 2025 (-9.9% net margin).
Dividend & Returns
Masimo Corporation (MASI) has a return on equity (ROE) of -17.1%. Negative ROE indicates the company is unprofitable.
Masimo Corporation (MASI) generated $211.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.